News

Innovative Advances Showcased at Legend Biotech's ASH Meeting

Innovative Advances Showcased at Legend Biotech's ASH Meeting

Impressive Presentations by Legend Biotech at the ASH Annual Meeting

Legend Biotech Corporation (NASDAQ: LEGN) recently made headlines by announcing its participation in the 67th Annual American Society of Hematology (ASH) Annual Meeting, where it will present two oral and seven poster presentations focused on CARVYKTI (ciltacabtagene autoleucel, cilta-cel), an innovative therapy for multiple myeloma.

Advancements in CARVYKTI Research

These presentations are poised to bolster the understanding of CARVYKTI, which is the first and only BCMA-targeted CAR-T cell therapy approved for patients with multiple myeloma who have undergone at least one prior treatment. The upcoming ASH event, taking place from December 6-9, 2025, will showcase critical data regarding the efficacy and safety of this treatment, reflecting the continuous innovation within the company.

Highlighting Oral Presentations

Among the oral presentations, Legend Biotech will share significant findings about long-term progression-free survival benefits associated with CARVYKTI in standard-risk relapsed/refractory multiple myeloma. This compelling data will be discussed in a session dedicated to optimizing immune-based therapies in myeloma treatment.

Poster Presentations to Note

In addition, the company's poster presentations will delve into various aspects of CARVYKTI's clinical performance, including the effectiveness of bridging therapy and comparative efficacy analyses with existing treatments. Notably, these insights draw from comprehensive studies that highlight the durability and real-world outcomes of CARVYKTI therapy.

Focus on Allogeneic CAR-T Cell Therapy

Legend Biotech will also present first-in-human data regarding Lucar-G39D, a novel investigational anti-CD20/CD19 dual-CAR allogeneic gamma delta T cell therapy aimed at treating relapsed or refractory B-cell non-Hodgkin lymphoma (NHL). The exploration of this innovative therapy underscores the company's commitment to expanding its treatment pipeline and providing new hope for patients battling hematological malignancies.

Executive Insights on CARVYKTI

Ying Huang, Ph.D., Chief Executive Officer of Legend Biotech, expressed pride in the company's ongoing advancements. He stated, "These presentations further demonstrate the durability of responses and evolving safety profile of CAR-T therapy earlier in the multiple myeloma treatment journey, highlighting our commitment to innovation in this space."

Living Up to Expectations

With over 9,000 patients treated globally, CARVYKTI significantly impacts multiple myeloma care today, catering to a critical need in hematology. The ongoing results from ASH will undoubtedly contribute further to its already established reputation.

Networking and Future Directions

The ASH Annual Meeting serves not only as a platform for presenting key research findings but also as a networking opportunity for professionals dedicated to advancing hematology. Through participation in this prestigious event, Legend Biotech continues to reinforce its role as a leader in the cell therapy landscape.

Frequently Asked Questions

What is CARVYKTI?

CARVYKTI is a BCMA-targeted CAR-T cell therapy approved for treating multiple myeloma in patients who have had at least one prior therapy.

When will Legend Biotech present at ASH?

Legend Biotech will present its findings at the 67th ASH Annual Meeting, scheduled for December 6-9, 2025.

What kinds of presentations will Legend Biotech showcase?

They will showcase two oral presentations and seven poster presentations related to CARVYKTI therapy and novel allogeneic treatments.

How has CARVYKTI been received globally?

CARVYKTI has been made commercially available in 14 countries and has treated over 9,000 patients, indicating a positive reception in the market.

What future developments can we expect from Legend Biotech?

Legend Biotech aims to expand its portfolio of cell therapies and continue to innovate in the treatment landscape for hematological cancers.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Laboratory Filtration Market Expands to $6.55B by 2031

Updated Category News Views 68

A Niche Ready to Explode The laboratory filtration market isn't exactly the sort of thing that grabs headlines in the business section, but its growth is worth giving a second look. By 2031, this market's expected to hit $6.55 billion—up from $4.49 billion in 2026. If you think that's not impressive, chew on a 7.9% CAGR for the next few years. That's like watching your...

Continue Reading
Christian Faith: Navigating Spiritual Pitfalls Wisely

Updated Category News Views 126

Taking a Deep Look at Christian Faith If you think faith is as simple as saying a few prayers and checking church attendance off the list, well, think again. G. Joseph Johnson, in his thought-provoking tome "Roads, Ditches, Traps, and Snares," believes that faith is a journey filled with twists, turns, and yes, a few traps. This book is a sort of roadmap for Christians,...

Continue Reading
Galileo's Robot Dog Takes Charge in Polish Warehouses

Updated Category News Views 204

Robotic Innovation Makes Waves in Europe You ever think you’d see the day when a dog—albeit a robotic one—takes the night shift at a warehouse? Well, here we are. Galileo Robotics has unleashed its C1-W robot dog in Poznan, Poland, and it's more than just a fancy tech gimmick. This thing's got potential, bridging gaps left wide open by human labor shortages and...

Continue Reading
Older Adults Embrace Cosmetic Dentistry for Confidence

Updated Category News Views 94

Why the Shift to Cosmetic Dentistry Later in Life? Aging doesn't just wrinkle your skin; it affects your smile too. Dr. Joseph T. Sumrall and Dr. Gran Sumrall, the dental gurus of Warner Robins, Georgia, are laying out why more adults are jumping on the cosmetic dentistry bandwagon as they age. Spoiler: It ain't about getting a movie-star grin but something much deeper....

Continue Reading
Fuel Cell Market Faces Uneven Growth Amid Revenue Shifts

Updated Category News Views 60

Fuel Cell Sector Eyes Mixed Results and Big Projections The fuel cell market, oh what a beast it's becoming—a story filled with ups and downs, and more forecasts than a weather station. As we stand, this sector is poised to balloon to an $18.16 billion market by 2030. That's a growth rate of 26.3% annually, folks. These projections are driving excitement, but the...

Continue Reading
Ericsson Completes Major Buyback in November Burst

Updated Category News Views 94

Ericsson's Aggressive Share Repurchase Strategy Ericsson's share buyback spree might not be the first rodeo for seasoned investors out there, but their recent grab between November 9th and 13th surely made a few heads turn. The telecom giant snatched up a neat pile of 500,000 of its own Class B shares, maintaining the steady tick of their ambitious buyback program. It's...

Continue Reading
DEFSEC Completes 9-to-1 Share Consolidation

Updated Category News Views 79

DEFSEC Technologies Tightens the Belt So, DEFSEC Technologies just pulled off something that'll kick up dust among investors. A 9-to-1 share consolidation—now that's no small fry. For those riding the NASDAQ or the TSX Venture with a tight grip on their DEFSEC shares, it's strictly business today. Post-consolidation, DEFSEC's common shares are set to trade under the...

Continue Reading
Nord Anglia Schools Shine with 13 Tes Awards Nominations

Updated Category News Views 146

Nord Anglia's Moment of Glory at Tes Awards You think you know the big players in the educational game? Well, guess again. Nord Anglia's come out swinging with a whopping 13 finalist nominations at the 2026 Tes Awards for International Schools. It ain't easy making waves in the education sector, but these folks are showing they've got what it takes to turn heads, not just...

Continue Reading
Zettia R. Barnes: Charting a Path in Home Healthcare

Updated Category News Views 95

The Lifeline of Home Healthcare in DeSoto You know, it ain't every day that someone like Zettia R. Barnes steps up in the realm of home healthcare and makes a mark that genuinely sticks. From rubbing shoulders with patients to steering a whole dang organization like Angels of Hands Home Health Agency Corp., she's got her hands full—and frankly, it’s folks like her who...

Continue Reading
Flexible Packaging Market to Hit $384.32B by 2031

Updated Category News Views 50

Packaging's Flexible Future Alright, here's the skinny: you might want to adjust those portfolios if you're watching the materials sector, because the flexible packaging market ain't just loosening up—it's stretching out like never before. By 2031, we're talking about it raking in a solid $384.32 billion, climbing from $313.25 billion in 2026. That's a not-so-shabby...

Continue Reading

Top 5 Most Recently Viewed Articles

Forecasting a Surge: Aerial Work Platforms Market Insights

Updated Category News Views 111

Growth Forecast for Aerial Work Platforms Market The aerial work platforms (AWPs) market is projected to witness significant growth from 2025 to 2035. As safety regulations become more stringent and construction activities continue to rise, the demand for these platforms is expected to expand markedly. Currently valued at approximately USD 12.1 billion in 2025, industry...

Continue Reading
Three Defensive Stocks to Watch in the Consumer Staples Sector

Updated Category News Views 38

Three Defensive Stocks to Keep an Eye On This month, attention is drawn to three standout stocks in the consumer staples sector that have sparked interest among investors focused on stability and long-term growth. Understanding Momentum Indicators Momentum indicators, such as the Relative Strength Index (RSI), play a crucial role in trading decisions. The RSI measures how...

Continue Reading
Challenges Facing Homeownership in Canada: Key Insights Revealed

Updated Category News Views 196

Significant Barriers to Homeownership in Canada Recent findings highlight that 32% of Canadians are being blocked from purchasing their homes due to the challenge of saving for a down payment. This survey, conducted by CPA Canada and BDO Debt Solutions, reflects the increasing financial strain on potential homeowners amidst rising rent prices and stagnant wages....

Continue Reading
Walmex Antitrust Case Update: Insight from Company Executives

Updated Category News Views 115

Walmex Antitrust Case Update: Insight from Company Executives In the bustling retail landscape of Mexico, Walmex, the renowned local division of Walmart (NYSE: WMT), is under the discerning gaze of the antitrust authorities. The company is eagerly awaiting a crucial decision from the Federal Economic Competition Commission, commonly known as Cofece. This ruling is...

Continue Reading
Innovative EIF Catalyst Program Enhances EdTech Growth Opportunities

Updated Category News Views 267

EIF Catalyst, A Game-Changer for EdTech Entrepreneurs In a bold move to elevate the EdTech and workforce sectors, ECMC Group's Education Impact Fund has introduced the EIF Catalyst program. This initiative aims to support founders who are eager to scale their businesses but require guidance and investment. Transformative Educational Program The EIF Catalyst is a...

Continue Reading